TCT 2021
Transplantation & Cellular Therapy
February 8-12, 2021
All-Virtual Meeting
Fred Hutch scientists are presenting new research findings at the Transplantation & Cellular Therapy (TCT) Meetings. The TCT represents the combined annual meetings of the American Society for Blood and Marrow Transplantation (ASBMT) and the Center for International Blood & Marrow Transplant Research (CIBMTR).
The meeting features the E. Donnall Thomas Lecture, named after the late Nobel laureate who pioneered bone marrow transplantation at Fred Hutch. The honor recognizes an eminent physician or scientist who has contributed meritoriously to the advancement of knowledge in blood and marrow transplantation.
Fred Hutch and Seattle Cancer Care Alliance will co-host a virtual booth at the meeting.
Highlights of Fred Hutch Presentations
Session: Snapshots From the COVID-19 Pandemic in Transplant Centers Across the US
Presenters: Micheal Boeckh, M.D., Ph.D., Steven Pergam, M.D., M.P.H., and Alpana Waghmare, M.D.
Friday, Feb. 5, 6-8 a.m. PST
Oral Presentation: Ruxolitinib (RUX) Vs Best Available Therapy (BAT) in Patients (Pts) with Glucocorticoid-Refractory Chronic Graft-Vs-Host Disease (cGVHD): Primary Findings from the Phase 3, Randomized REACH3 Study
Presenter: Stephanie Lee, M.D., M.P.H.
Thursday, Feb. 11, 1:15-1:30 p.m. PST
Oral Presentation: Which Respiratory Virus Infections Are Associated with Increased Risk of Specific Bacterial Infection in Allogeneic Hematopoietic Cell Transplant Recipients?
Presenter: Chikara Ogimi, M.D.
Thursday, Feb. 11, 1-1:15 p.m. PST
Oral Presentation: Novel, Gene-Level Associations between the Microbiome and MAIT or Treg Reconstitution after Allogeneic HSCT
Presenter: Salvatore Fiorenza, M.B.B.S., Ph.D., M.P.H.
Thursday, Feb. 11, 2:15-2:30 p.m. PST
Join Us at Our Virtual Booth
Fred Hutch and Seattle Cancer Care Alliance are hosting a virtual booth during the TCT meeting. TCT participants may join us.
Visit the Seattle Cancer Care Alliance TCT webpage.
Contact Our Media Relations Team
For more information or to arrange an interview, please email or call our media relations team.